How important is differentiation in the therapeutic effect of mesenchymal stromal cells in liver disease?

Cytotherapy

Volumn 16, Issue 3, 2014, Pages 309-318

  Wang, Hanyu ^a   Zhao, Tingting ^a   Xu, Fang ^a   Li, Yan ^a   Wu, Mingyuan ^a,b,c   Zhu, Delin ^a   Cong, Xiuli ^a,d   Liu, Yongjun ^a  

^a Alliancells Institute of Stem Cells and Translational Regenerative Medicine   (China)

^b Beijing Alliancells PuRui Bioscience Co Ltd   (China)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Cytotherapy; Differentiation; Liver diseases; Mesenchymal stromal cells

Indexed keywords

CYTOTHERAPY; DIFFERENTIATION; LIVER DISEASES; MESENCHYMAL STROMAL CELLS;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; CELL ADHESION MOLECULES; CELL DIFFERENTIATION; CELLS, CULTURED; HEPATOCYTE GROWTH FACTOR; HEPATOCYTES; HUMANS; LIVER; LIVER FAILURE, ACUTE; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED BALB C; RECEPTORS, CXCR4; UMBILICAL CORD;

EID: 84895085507     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2013.07.011     Document Type: Article

References (46)

1. Lavon N., Yanuka O., Benvenisty N. Differentiation and isolation of hepatic-like cells from human embryonic stem cells. Differentiation 2004, 72:230-238.
2. Hamazaki T., Iiboshi Y., Oka M., Papst P.J., Meacham A.M., Zon L.I., et al. Hepatic maturation in differentiating embryonic stem cells in vitro. FEBS Lett 2001, 497:15-19.
3. Lee K.D., Kuo T.K., Whang-Peng J., Chung Y.F., Lin C.T., Chou S.H., et al. In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology 2004, 40:1275-1284.
4. Schwartz R.E., Reyes M., Koodie L., Jiang Y., Blackstad M., Lund T., et al. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. JClin Invest 2002, 109:1291-1302.
5. Aurich H., Sgodda M., Kaltwasser P., Vetter M., Weise A., Liehr T., et al. Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo. Gut 2009, 58:570-581.
6. Muraca M. Cell therapy as support or alternative to liver transplantation. Transplant Proc 2003, 35:1047-1048.
7. Basma H., Soto-Gutierrez A., Yannam G.R., Liu L., Ito R., Yamamoto T., et al. Differentiation and transplantation of human embryonic stem cell-derived hepatocytes. Gastroenterology 2009, 136:990-999.
8. Kroon E., Martinson L.A., Kadoya K., Bang A.G., Kelly O.G., Eliazer S., et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol 2008, 26:443-452.
9. Werbowetski-Ogilvie T.E., Bosse M., Stewart M., Schnerch A., Ramos-Mejia V., Rouleau A., et al. Characterization of human embryonic stem cells with features of neoplastic progression. Nat Biotechnol 2009, 27:91-97.
10. Kuo T.K., Hung S.P., Chuang C.H., Chen C.T., Shih Y.R., Fang S.C., et al. Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology 2008, 134:2111-2121.
11. Togel F., Hu Z., Weiss K., Isaac J., Lange C., Westenfelder C. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol 2005, 289:F31-F42.
12. Sato Y., Araki H., Kato J., Nakamura K., Kawano Y., Kobune M., et al. Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion. Blood 2005, 106:756-763.
13. Miyahara Y., Nagaya N., Kataoka M., Yanagawa B., Tanaka K., Hao H., et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med 2006, 12:459-465.
14. Gnecchi M., He H., Liang O.D., Melo L.G., Morello F., Mu H., et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 2005, 11:367-368.
15. Aurich I., Mueller L.P., Aurich H., Luetzkendorf J., Tisljar K., Dollinger M.M., et al. Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers. Gut 2007, 56:405-415.
16. Banas A., Teratani T., Yamamoto Y., Tokuhara M., Takeshita F., Osaki M., et al. Rapid hepatic fate specification of adipose-derived stem cells and their therapeutic potential for liver failure. JGastroenterol Hepatol 2009, 24:70-77.
17. Zhang D., Jiang M., Miao D. Transplanted human amniotic membrane-derived mesenchymal stem cells ameliorate carbon tetrachloride-induced liver cirrhosis in mouse. PLoS One 2011, 6:e16789.
18. Lin S.Z., Chang Y.J., Liu J.W., Chang L.F., Sun L.Y., Li Y.S., et al. Transplantation of human Wharton's Jelly-derived stem cells alleviates chemically induced liver fibrosis in rats. Cell Transplant 2010, 19:1451-1463.
19. Tsai P.C., Fu T.W., Chen Y.M., Ko T.L., Chen T.H., Shih Y.H., et al. The therapeutic potential of human umbilical mesenchymal stem cells from Wharton's jelly in the treatment of rat liver fibrosis. Liver Transpl 2009, 15:484-495.
20. Stock P., Bruckner S., Ebensing S., Hempel M., Dollinger M.M., Christ B. The generation of hepatocytes from mesenchymal stem cells and engraftment into murine liver. Nat Protoc 2010, 5:617-627.
21. Banas A., Teratani T., Yamamoto Y., Tokuhara M., Takeshita F., Osaki M., et al. IFATS collection: in vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury. Stem Cells 2008, 26:2705-2712.
22. Parekkadan B., van Poll D., Suganuma K., Carter E.A., Berthiaume F., Tilles A.W., et al. Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. PLoS One 2007, 2:e941.
23. Lam S.P., Luk J.M., Man K., Ng K.T., Cheung C.K., Rose-John S., et al. Activation of interleukin-6-induced glycoprotein 130/signal transducer and activator of transcription 3 pathway in mesenchymal stem cells enhances hepatic differentiation, proliferation, and liver regeneration. Liver Transpl 2010, 16:1195-1206.
24. van Poll D., Parekkadan B., Cho C.H., Berthiaume F., Nahmias Y., Tilles A.W., et al. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology 2008, 47:1634-1643.
25. Lu L.L., Liu Y.J., Yang S.G., Zhao Q.J., Wang X., Gong W., et al. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica 2006, 91:1017-1026.
26. Liao W., Xie J., Zhong J., Liu Y., Du L., Zhou B., et al. Therapeutic effect of human umbilical cord multipotent mesenchymal stromal cells in a rat model of stroke. Transplantation 2009, 87:350-359.
27. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., et al. Minimal criteria for defining multipotent mesenchymal stromal cells: the International Society for Cellular Therapy position statement. Cytotherapy 2006, 8:315-317.
28. Di Nicola M., Carlo-Stella C., Magni M., Milanesi M., Longoni P.D., Matteucci P., et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002, 99:3838-3843.
29. Bartholomew A., Sturgeon C., Siatskas M., Ferrer K., McIntosh K., Patil S., et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002, 30:42-48.
30. Wang H., Pang B., Li Y., Zhu D., Pang T., Liu Y. Dexamethasone has variable effects on mesenchymal stromal cells. Cytotherapy 2012, 14:423-430.
31. Chen K., Wang D., Du W.T., Han Z.B., Ren H., Chi Y., et al. Human umbilical cord mesenchymal stem cells hUC-MSCs exert immunosuppressive activities through a PGE2-dependent mechanism. Clin Immunol 2010, 135:448-458.
32. Vaquero C., Sanceau J., Weissenbach J., Beranger F., Falcoff R. Regulation of human gamma-interferon and beta-interferon gene expression in PHA-activated lymphocytes. JInterferon Res 1986, 6:161-170.
33. Ishii T., Sato M., Sudo K., Suzuki M., Nakai H., Hishida T., et al. Hepatocyte growth factor stimulates liver regeneration and elevates blood protein level in normal and partially hepatectomized rats. JBiochem 1995, 117:1105-1112.
34. Fujiwara K., Nagoshi S., Ohno A., Hirata K., Ohta Y., Mochida S., et al. Stimulation of liver growth by exogenous human hepatocyte growth factor in normal and partially hepatectomized rats. Hepatology 1993, 18:1443-1449.
35. Matsumoto K., Nakamura T. Hepatocyte growth factor: molecular structure and implications for a central role in liver regeneration. JGastroenterol Hepatol 1991, 6:509-519.
36. Friedman R., Betancur M., Boissel L., Tuncer H., Cetrulo C., Klingemann H. Umbilical cord mesenchymal stem cells: adjuvants for human cell transplantation. Biol Blood Marrow Transplant 2007, 13:1477-1486.
37. Chen Y., Kobayashi N., Suzuki S., Soto-Gutierrez A., Rivas-Carrillo J.D., Tanaka K., et al. Transplantation of human hepatocytes cultured with deleted variant of hepatocyte growth factor prolongs the survival of mice with acute liver failure. Transplantation 2005, 79:1378-1385.
38. Sun J., Han Z.B., Liao W., Yang S.G., Yang Z., Yu J., et al. Intrapulmonary delivery of human umbilical cord mesenchymal stem cells attenuates acute lung injury by expanding CD4+CD25+ Forkhead Boxp3 (FOXP3)+ regulatory T cells and balancing anti- and pro-inflammatory factors. Cell Physiol Biochem 2011, 27:587-596.
39. Prockop D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997, 276:71-74.
40. Prockop D.J., Kota D.J., Bazhanov N., Reger R.L. Evolving paradigms for repair of tissues by adult stem/progenitor cells (MSCs). JCell Mol Med 2010, 14:2190-2199.
41. Watanabe M., Murata S., Hashimoto I., Nakano Y., Ikeda O., Aoyagi Y., et al. Platelets contribute to the reduction of liver fibrosis in mice. JGastroenterol Hepatol 2009, 24:78-89.
42. Munoz J.R., Stoutenger B.R., Robinson A.P., Spees J.L., Prockop D.J. Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice. Proc Natl Acad Sci U S A 2005, 102:18171-18176.
43. Hasuike S., Ido A., Uto H., Moriuchi A., Tahara Y., Numata M., et al. Hepatocyte growth factor accelerates the proliferation of hepatic oval cells and possibly promotes the differentiation in a 2-acetylaminofluorene/partial hepatectomy model in rats. JGastroenterol Hepatol 2005, 20:1753-1761.
44. Suzuki H., Toyoda M., Horiguchi N., Kakizaki S., Ohyama T., Takizawa D., et al. Hepatocyte growth factor protects against Fas-mediated liver apoptosis in transgenic mice. Liver Int 2009, 29:1562-1568.
45. Kosai K., Matsumoto K., Nagata S., Tsujimoto Y., Nakamura T. Abrogation of Fas-induced fulminant hepatic failure in mice by hepatocyte growth factor. Biochem Biophys Res Commun 1998, 244:683-690.
46. Ishii K., Yoshida Y., Akechi Y., Sakabe T., Nishio R., Ikeda R., et al. Hepatic differentiation of human bone marrow-derived mesenchymal stem cells by tetracycline-regulated hepatocyte nuclear factor 3beta. Hepatology 2008, 48:597-606.